Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -6.83
- Piotroski Score 3.00
- Grade Outperform
- Symbol (AKLI)
- Company Akili, Inc.
- Price $0.43
- Changes Percentage (0.25%)
- Change -$0
- Day Low $0.43
- Day High $0.43
- Year High $1.25
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/08/2024
- Fiscal Year End N/A
- Average Stock Price Target $3.25
- High Stock Price Target $4.50
- Low Stock Price Target $2.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.61
- Trailing P/E Ratio -0.69
- Forward P/E Ratio -0.69
- P/E Growth -0.69
- Net Income $-59,493,000
